Abstract

Background: Stenotrophomonas maltophilia is a multidrug-resistant, Gram negative bacillus that has emerged as an opportunistic pathogen associated with high morbidity and mortality rates. Aim: The aim of this study is to describe the characteristics of patients with bloodstream infec- tions due to S. maltophilia. Methods: A descriptive retrospective study was performed at the ICUs over seven-year period in a teaching hospital. Cases of SMB were identified through a review of clinical microbiology laboratory and patient's records were retrieved for analysis. Findings: There were 22 deaths (71%) 15 ± 12 days after the bactaeremia. In our study, more than half of patients (17/31) was exposed to broad-spectrum antibiotic specifically imipinem (IMP) before their posi- tive culture. Antibiotic susceptibility testing revealed that isolates were most sensitive to ciprof- loxacin (84%) and to trimethoprim-sulfamethoxazole (71%). A probable portal of entry was iden- tified in 27.3% of cases and 57% were catheter-related. Conclusion: Our results were similar to those described by other authors reported in the literature in the last 20 years. Prevention of S. maltophilia acquisition and infection depends on higher emphasis on control of antimicrobial consumption and consideration of environmental reservoirs.

Highlights

  • P206: Stenotrophomonas maltophilia bacteraemia: analysis of 33 episodes occurred in the ICU at the University Hospital in Sousse-Tunisia

  • Stenotrophomonas maltophilia is a gram negative bacillus that has emerged as an opportunistic pathogen associated with high morbidity and mortality rates

  • 23 (74%) patient had mechanical ventilation and 29 (93·5%) had central venous catheterization

Read more

Summary

Open Access

P206: Stenotrophomonas maltophilia bacteraemia: analysis of 33 episodes occurred in the ICU at the University Hospital in Sousse-Tunisia. O Bouallègue*, N Jaidane, H Said laatiri, W Naija, S Khefecha Aissa, N Boujaafar, L Dhidah. From 2nd International Conference on Prevention and Infection Control (ICPIC 2013) Geneva, Switzerland. From 2nd International Conference on Prevention and Infection Control (ICPIC 2013) Geneva, Switzerland. 25-28 June 2013

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.